AKT1 and cancer: Various factors, including PIF (tumor-derived factor), myostatin (skeletal muscle-derived factor), and cytokines, such as TNF-α and IL-6, can facilitate skeletal muscle depletion by inhibiting the PI3K/Akt signaling in cancer cachexia.